DRD2 C957T polymorphism is associated with improved 6-month verbal learning following traumatic brain injury

Neurogenetics. 2017 Jan;18(1):29-38. doi: 10.1007/s10048-016-0500-6. Epub 2016 Nov 8.

Abstract

Traumatic brain injury (TBI) often leads to heterogeneous clinical outcomes, which may be influenced by genetic variation. A single-nucleotide polymorphism (SNP) in the dopamine D2 receptor (DRD2) may influence cognitive deficits following TBI. However, part of the association with DRD2 has been attributed to genetic variability within the adjacent ankyrin repeat and kinase domain containing 1 protein (ANKK1). Here, we utilize the Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study to investigate whether a novel DRD2 C957T polymorphism (rs6277) influences outcome on a cognitive battery at 6 months following TBI-California Verbal Learning Test (CVLT-II), Wechsler Adult Intelligence Test Processing Speed Index Composite Score (WAIS-PSI), and Trail Making Test (TMT). Results in 128 Caucasian subjects show that the rs6277 T-allele associates with better verbal learning and recall on CVLT-II Trials 1-5 (T-allele carrier 52.8 ± 1.3 points, C/C 47.9 ± 1.7 points; mean increase 4.9 points, 95% confidence interval [0.9 to 8.8]; p = 0.018), Short-Delay Free Recall (T-carrier 10.9 ± 0.4 points, C/C 9.7 ± 0.5 points; mean increase 1.2 points [0.1 to 2.5]; p = 0.046), and Long-Delay Free Recall (T-carrier 11.5 ± 0.4 points, C/C 10.2 ± 0.5 points; mean increase 1.3 points [0.1 to 2.5]; p = 0.041) after adjusting for age, education years, Glasgow Coma Scale, presence of acute intracranial pathology on head computed tomography scan, and genotype of the ANKK1 SNP rs1800497 using multivariable regression. No association was found between DRD2 C947T and non-verbal processing speed (WAIS-PSI) or mental flexibility (TMT) at 6 months. Hence, DRD2 C947T (rs6277) may be associated with better performance on select cognitive domains independent of ANKK1 following TBI.

Trial registration: ClinicalTrials.gov NCT01565551.

Keywords: Cognition; Genetic factors; Human studies; Outcome measures; Traumatic brain injury.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adult
  • Brain Injuries, Traumatic / genetics
  • Brain Injuries, Traumatic / psychology
  • Brain Injuries, Traumatic / rehabilitation*
  • Case-Control Studies
  • Female
  • Genetic Association Studies
  • Humans
  • Male
  • Middle Aged
  • Neuronal Plasticity / genetics*
  • Pilot Projects
  • Polymorphism, Single Nucleotide*
  • Receptors, Dopamine D2 / genetics*
  • Verbal Learning / physiology*

Substances

  • DRD2 protein, human
  • Receptors, Dopamine D2

Associated data

  • ClinicalTrials.gov/NCT01565551